(0.14%) 5 106.96 points
(0.15%) 38 296 points
(0.10%) 15 943 points
(-1.25%) $82.80
(4.94%) $2.02
(0.08%) $2 349.10
(0.01%) $27.54
(3.89%) $958.00
(-0.17%) $0.933
(-0.23%) $11.00
(-0.44%) $0.797
(1.74%) $93.47
@ $136.62
发出时间: 29 Apr 2024 @ 21:30
回报率: 0.16%
上一信号: Apr 27 - 00:07
上一信号:
回报率: 0.79 %
Live Chart Being Loaded With Signals
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry...
Stats | |
---|---|
今日成交量 | 109 894 |
平均成交量 | 512 482 |
市值 | 7.24B |
EPS | $0 ( 2024-02-27 ) |
下一个收益日期 | ( $0.710 ) 2024-05-07 |
Last Dividend | $1.000 ( 2012-11-23 ) |
Next Dividend | $0 ( N/A ) |
P/E | 90.62 |
ATR14 | $2.35 (1.72%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Tripodi Blair | Buy | 30 000 | Restricted Stock Units |
2024-03-01 | Tripodi Blair | Buy | 9 127 | Non-Qualified Stock Option (Right to Buy) |
2024-03-01 | Muhsin Bilal | Buy | 30 000 | Restricted Stock Units |
2024-02-28 | Muhsin Bilal | Buy | 2 010 | Common Stock |
2024-02-28 | Muhsin Bilal | Sell | 745 | Common Stock |
INSIDER POWER |
---|
77.94 |
Last 93 transactions |
Buy: 793 924 | Sell: 148 839 |
音量 相关性
Masimo Corp 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Masimo Corp 相关性 - 货币/商品
Masimo Corp 财务报表
Annual | 2023 |
营收: | $2.05B |
毛利润: | $1.00B (49.00 %) |
EPS: | $1.540 |
FY | 2023 |
营收: | $2.05B |
毛利润: | $1.00B (49.00 %) |
EPS: | $1.540 |
FY | 2022 |
营收: | $2.04B |
毛利润: | $1.06B (52.01 %) |
EPS: | $2.68 |
FY | 2021 |
营收: | $1.24B |
毛利润: | $808.35M (65.23 %) |
EPS: | $4.16 |
Financial Reports:
No articles found.
Masimo Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $2.00 | 2010-03-09 |
Last Dividend | $1.000 | 2012-11-23 |
Next Dividend | $0 | N/A |
Payout Date | 2012-12-11 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $3.75 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.91 | -- |
Div. Sustainability Score | 9.50 | |
Div.Growth Potential Score | 1.722 | |
Div. Directional Score | 5.61 | -- |
Year | Amount | Yield |
---|---|---|
2010 | $2.75 | 9.24% |
2011 | $0 | 0.00% |
2012 | $1.000 | 5.31% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0398 | 1.500 | 9.20 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0268 | 1.200 | 9.11 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0618 | 1.500 | -0.425 | -0.637 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.18 | 0.800 | 4.08 | 3.26 | [1 - 3] |
quickRatioTTM | 1.041 | 0.800 | 8.58 | 6.87 | [0.8 - 2.5] |
cashRatioTTM | 0.294 | 1.500 | 9.48 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.304 | -1.500 | 4.94 | -7.40 | [0 - 0.6] |
interestCoverageTTM | 3.14 | 1.000 | 9.95 | 9.95 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.782 | 2.00 | 9.41 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.121 | 2.00 | 9.94 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.677 | -1.500 | 7.29 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.490 | 1.000 | 5.17 | 5.17 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0769 | 1.000 | -0.463 | -0.463 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.102 | 1.000 | -0.545 | -0.545 | [0.2 - 2] |
assetTurnoverTTM | 0.673 | 0.800 | 8.84 | 7.08 | [0.5 - 2] |
Total Score | 9.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 88.20 | 1.000 | 1.192 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0618 | 2.50 | -0.273 | -0.637 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.121 | 2.00 | 9.96 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.782 | 2.00 | 9.41 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.307 | 1.500 | -1.289 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0459 | 1.000 | -1.351 | 0 | [0.1 - 0.5] |
Total Score | 1.722 |
Masimo Corp
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。